PacRay International Holdings Limited Logo

PacRay International Holdings Limited

1010.HK

(0.5)
Stock Price

0,42 HKD

-0.48% ROA

29% ROE

-102.71x PER

Market Cap.

229.551.900,00 HKD

3.49% DER

0% Yield

5.14% NPM

PacRay International Holdings Limited Stock Analysis

PacRay International Holdings Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

PacRay International Holdings Limited Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (3%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 ROE

Negative ROE (-4.08%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

3 ROA

The stock's ROA (-0.48%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

4 PBV

The stock's elevated P/BV ratio (32.67x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

5 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

6 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

7 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

8 Graham Number

The Graham number calculation reveals that this company's stock price is potentially inflated, implying that it may not be a desirable investment option.

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (-845) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

PacRay International Holdings Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

PacRay International Holdings Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Buy
4 Stoch RSI Hold

PacRay International Holdings Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

PacRay International Holdings Limited Revenue
Year Revenue Growth
2002 76.233.000
2003 121.700.000 37.36%
2004 163.961.000 25.78%
2005 147.961.000 -10.81%
2006 125.552.000 -17.85%
2007 112.502.000 -11.6%
2008 88.237.000 -27.5%
2009 67.304.000 -31.1%
2010 86.689.000 22.36%
2011 12.436.000 -597.08%
2012 10.916.000 -13.92%
2013 12.218.000 10.66%
2014 13.646.000 10.46%
2015 13.614.000 -0.24%
2016 17.337.000 21.47%
2017 36.580.000 52.61%
2018 60.709.000 39.75%
2019 74.339.000 18.33%
2019 74.339.000 0%
2020 92.647.000 19.76%
2021 105.619.000 12.28%
2022 181.076.000 41.67%
2023 113.970.000 -58.88%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

PacRay International Holdings Limited Research and Development Expenses
Year Research and Development Expenses Growth
2002 0
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 270.000 100%
2014 58.000 -365.52%
2015 71.000 18.31%
2016 56.000 -26.79%
2017 201.000 72.14%
2018 0 0%
2019 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

PacRay International Holdings Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2002 27.430.000
2003 28.261.000 2.94%
2004 25.562.000 -10.56%
2005 31.742.000 19.47%
2006 31.334.000 -1.3%
2007 31.670.000 1.06%
2008 32.094.000 1.32%
2009 30.860.000 -4%
2010 35.928.000 14.11%
2011 19.625.000 -83.07%
2012 17.356.000 -13.07%
2013 18.481.000 6.09%
2014 16.239.000 -13.81%
2015 21.312.000 23.8%
2016 16.771.000 -27.08%
2017 23.218.000 27.77%
2018 46.937.000 50.53%
2019 46.288.000 -1.4%
2019 52.824.000 12.37%
2020 39.593.000 -33.42%
2021 49.114.000 19.39%
2022 47.588.000 -3.21%
2023 61.510.000 22.63%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

PacRay International Holdings Limited EBITDA
Year EBITDA Growth
2002 11.123.000
2003 226.013.000 95.08%
2004 -81.754.000 376.45%
2005 -22.000.000 -271.61%
2006 -3.460.000 -535.84%
2007 126.000 2846.03%
2008 -115.022.000 100.11%
2009 -14.355.000 -701.27%
2010 -12.258.000 -17.11%
2011 -3.692.000 -232.02%
2012 -7.710.000 52.11%
2013 -9.941.000 22.44%
2014 -6.711.000 -48.13%
2015 -12.885.000 47.92%
2016 -6.650.000 -93.76%
2017 -10.057.000 33.88%
2018 -35.440.000 71.62%
2019 -11.000.000 -222.18%
2019 -17.630.000 37.61%
2020 -11.831.000 -49.02%
2021 -25.505.000 53.61%
2022 9.091.000 380.55%
2023 -40.651.000 122.36%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

PacRay International Holdings Limited Gross Profit
Year Gross Profit Growth
2002 19.435.000
2003 39.957.000 51.36%
2004 45.949.000 13.04%
2005 31.662.000 -45.12%
2006 31.890.000 0.71%
2007 30.028.000 -6.2%
2008 21.162.000 -41.9%
2009 17.541.000 -20.64%
2010 25.101.000 30.12%
2011 8.474.000 -196.21%
2012 7.506.000 -12.9%
2013 8.029.000 6.51%
2014 8.961.000 10.4%
2015 7.824.000 -14.53%
2016 9.640.000 18.84%
2017 12.859.000 25.03%
2018 11.251.000 -14.29%
2019 19.801.000 43.18%
2019 19.801.000 0%
2020 23.965.000 17.38%
2021 35.664.000 32.8%
2022 84.595.000 57.84%
2023 31.559.000 -168.05%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

PacRay International Holdings Limited Net Profit
Year Net Profit Growth
2002 11.739.000
2003 216.712.000 94.58%
2004 -91.388.000 337.13%
2005 -23.639.000 -286.6%
2006 29.587.000 179.9%
2007 -62.536.000 147.31%
2008 -113.128.000 44.72%
2009 350.000 32422.29%
2010 14.890.000 97.65%
2011 -19.075.000 178.06%
2012 52.152.000 136.58%
2013 46.015.000 -13.34%
2014 17.268.000 -166.48%
2015 -25.253.000 168.38%
2016 -4.994.000 -405.67%
2017 -2.686.000 -85.93%
2018 -40.187.000 93.32%
2019 -22.714.000 -76.93%
2019 -21.065.000 -7.83%
2020 -5.495.000 -283.35%
2021 -52.840.000 89.6%
2022 -2.236.000 -2263.15%
2023 -46.447.000 95.19%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

PacRay International Holdings Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2002 0
2003 1 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

PacRay International Holdings Limited Free Cashflow
Year Free Cashflow Growth
2002 -23.163.000
2003 30.857.000 175.07%
2004 -19.529.000 258.01%
2005 16.376.000 219.25%
2006 7.016.000 -133.41%
2007 -13.024.000 153.87%
2008 -8.861.000 -46.98%
2009 -16.045.000 44.77%
2010 -16.722.000 4.05%
2011 -12.103.000 -38.16%
2012 -16.120.000 24.92%
2013 -11.831.000 -36.25%
2014 -7.450.000 -58.81%
2015 -15.069.000 50.56%
2016 -9.468.000 -59.16%
2017 -19.167.000 50.6%
2018 -35.032.000 45.29%
2019 -2.220.750 -1477.49%
2020 22.870.000 109.71%
2021 -133.850.000 117.09%
2022 19.502.000 786.34%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

PacRay International Holdings Limited Operating Cashflow
Year Operating Cashflow Growth
2002 -12.280.000
2003 32.506.000 137.78%
2004 -19.529.000 266.45%
2005 16.376.000 219.25%
2006 8.351.000 -96.1%
2007 -11.906.000 170.14%
2008 -8.590.000 -38.6%
2009 -15.669.000 45.18%
2010 -15.647.000 -0.14%
2011 -10.574.000 -47.98%
2012 -15.688.000 32.6%
2013 -10.315.000 -52.09%
2014 -6.439.000 -60.2%
2015 -14.218.000 54.71%
2016 -8.977.000 -58.38%
2017 -18.527.000 51.55%
2018 -32.077.000 42.24%
2019 -2.010.000 -1495.87%
2020 22.884.000 108.78%
2021 -132.050.000 117.33%
2022 19.527.000 776.24%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

PacRay International Holdings Limited Capital Expenditure
Year Capital Expenditure Growth
2002 10.883.000
2003 1.649.000 -559.98%
2004 0 0%
2005 0 0%
2006 1.335.000 100%
2007 1.118.000 -19.41%
2008 271.000 -312.55%
2009 376.000 27.93%
2010 1.075.000 65.02%
2011 1.529.000 29.69%
2012 432.000 -253.94%
2013 1.516.000 71.5%
2014 1.011.000 -49.95%
2015 851.000 -18.8%
2016 491.000 -73.32%
2017 640.000 23.28%
2018 2.955.000 78.34%
2019 210.750 -1302.14%
2020 14.000 -1405.36%
2021 1.800.000 99.22%
2022 25.000 -7100%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

PacRay International Holdings Limited Equity
Year Equity Growth
2002 131.931.000
2003 344.666.000 61.72%
2004 256.072.000 -34.6%
2005 229.735.000 -11.46%
2006 256.677.000 10.5%
2007 205.074.000 -25.16%
2008 121.116.000 -69.32%
2009 84.044.000 -44.11%
2010 103.289.000 18.63%
2011 82.223.000 -25.62%
2012 129.936.000 36.72%
2013 176.140.000 26.23%
2014 193.265.000 8.86%
2015 167.442.000 -15.42%
2016 153.229.000 -9.28%
2017 161.103.000 4.89%
2018 118.348.000 -36.13%
2019 95.911.000 -23.39%
2020 107.286.000 10.6%
2021 62.550.000 -71.52%
2022 47.165.000 -32.62%
2023 37.613.000 -25.4%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

PacRay International Holdings Limited Assets
Year Assets Growth
2002 253.062.000
2003 474.313.000 46.65%
2004 327.814.000 -44.69%
2005 301.907.000 -8.58%
2006 331.800.000 9.01%
2007 216.979.000 -52.92%
2008 140.406.000 -54.54%
2009 134.757.000 -4.19%
2010 157.864.000 14.64%
2011 118.175.000 -33.58%
2012 137.579.000 14.1%
2013 180.284.000 23.69%
2014 196.737.000 8.36%
2015 170.168.000 -15.61%
2016 155.827.000 -9.2%
2017 164.151.000 5.07%
2018 122.967.000 -33.49%
2019 164.843.000 25.4%
2020 157.568.000 -4.62%
2021 295.044.000 46.6%
2022 461.955.000 36.13%
2023 412.709.000 -11.93%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

PacRay International Holdings Limited Liabilities
Year Liabilities Growth
2002 94.309.000
2003 93.468.000 -0.9%
2004 27.550.000 -239.27%
2005 30.711.000 10.29%
2006 31.760.000 3.3%
2007 11.905.000 -166.78%
2008 19.290.000 38.28%
2009 15.558.000 -23.99%
2010 18.887.000 17.63%
2011 21.283.000 11.26%
2012 7.643.000 -178.46%
2013 4.144.000 -84.44%
2014 3.472.000 -19.35%
2015 2.726.000 -27.37%
2016 2.598.000 -4.93%
2017 3.048.000 14.76%
2018 4.619.000 34.01%
2019 68.932.000 93.3%
2020 50.282.000 -37.09%
2021 232.494.000 78.37%
2022 414.790.000 43.95%
2023 375.096.000 -10.58%

PacRay International Holdings Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.49
Net Income per Share
-0.01
Price to Earning Ratio
-102.71x
Price To Sales Ratio
1.27x
POCF Ratio
11.76
PFCF Ratio
11.77
Price to Book Ratio
4.87
EV to Sales
0.7
EV Over EBITDA
10.55
EV to Operating CashFlow
6.5
EV to FreeCashFlow
6.51
Earnings Yield
-0.01
FreeCashFlow Yield
0.08
Market Cap
0,23 Bil.
Enterprise Value
0,13 Bil.
Graham Number
0.13
Graham NetNet
-0.6

Income Statement Metrics

Net Income per Share
-0.01
Income Quality
5.73
ROE
-0.04
Return On Assets
0.03
Return On Capital Employed
0.63
Net Income per EBT
0.55
EBT Per Ebit
0.86
Ebit per Revenue
0.11
Effective Tax Rate
0.45

Margins

Sales, General, & Administrative to Revenue
0.26
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.42
Operating Profit Margin
0.11
Pretax Profit Margin
0.09
Net Profit Margin
0.05

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.05
Free CashFlow per Share
0.05
Capex to Operating CashFlow
-0
Capex to Revenue
-0
Capex to Depreciation
-0.01
Return on Invested Capital
-0.13
Return on Tangible Assets
-0
Days Sales Outstanding
0
Days Payables Outstanding
251.19
Days of Inventory on Hand
658.31
Receivables Turnover
0
Payables Turnover
1.45
Inventory Turnover
0.55
Capex per Share
-0

Balance Sheet

Cash per Share
0,28
Book Value per Share
0,13
Tangible Book Value per Share
0.13
Shareholders Equity per Share
0.13
Interest Debt per Share
0.02
Debt to Equity
0.03
Debt to Assets
0
Net Debt to EBITDA
-8.54
Current Ratio
1.02
Tangible Asset Value
0,05 Bil.
Net Current Asset Value
0,01 Bil.
Invested Capital
0.03
Working Capital
0,01 Bil.
Intangibles to Total Assets
-0.01
Average Receivables
0,00 Bil.
Average Payables
0,04 Bil.
Average Inventory
87679500
Debt to Market Cap
0.01

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

PacRay International Holdings Limited Dividends
Year Dividends Growth
1994 0
1995 0 0%

PacRay International Holdings Limited Profile

About PacRay International Holdings Limited

PacRay International Holdings Limited, an investment holding company, engages in the design, distribution, and trade of integrated circuits and semiconductor parts in the People's Republic of China and Hong Kong. It also offers agency services related to integrated circuits and semiconductor parts. The company's integrated circuits are used in industrial and household measuring tools and display products. In addition, it is involved in the sale of yachts and property investment businesses, as well as provides jet business management, aircraft selling, pilot training, and yacht management services. The company was formerly known as PacMOS Technologies Holdings Limited and changed its name to PacRay International Holdings Limited in December 2015. PacRay International Holdings Limited is based in Central, Hong Kong.

CEO
Mr. Fuk Tak Lam
Employee
94
Address
Agricultural Bank of China Tower
Central,

PacRay International Holdings Limited Executives & BODs

PacRay International Holdings Limited Executives & BODs
# Name Age
1 Mr. Wai Kei Lam
Company Secretary
70
2 Dr. Yu Zhang
Executive Director
70
3 Mr. Fuk Tak Lam
Chief Executive Officer
70
4 Ms. Weina Li
Executive Director
70
5 Mr. Fumin Zhang
Executive Director
70

PacRay International Holdings Limited Competitors